Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura

George Goshua, MD, Pranay Sinha, MD, Jeanne E. Hendrickson, MD, Christopher A. Tormey, MD, Pavan Bendapudi, MD, Alfred Ian Lee, MD PhD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-138515

Published: 2020

Journal Articles

Incidence and Risk Factors for Bleeding in Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

Jurjen Versluis, Yael Flamand, MS, Erika J. Haydu, MD PhD, Rahul S. Vedula, MD, Anne Charles, BS, Kevin Copson, MA, Ofir Wolach, MD, Pavan Bendapudi, MD, Roger Belizaire, MD PhD, Donna S. Neuberg, ScD, Marlise R Luskin, MDMS, R. Coleman Lindsley, MD PhD

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-137741

Published: 2020

Journal Articles

Rare Inherited Defects of the Complement System in Purpura Fulminans

Pavan Bendapudi, MD, Justine Ryu, MD, Onuralp Soylemez, Betty Rouaisnel, Meaghan Colling, MD, Bryce Pasko, Alissa Robbins, Michael Bouzinier, Lindsay Tomczak, Sanjay Ram, Agnes Toth-Petroczy, Joel Krier, Elizabeth Fieg, Walter Dzik, MD, James Hudspeth, MD, Olga Pozdnyakova, MD PhD, Valentina Nardi, MD, Richard Maas, Julie-Aurore Losman, MD PhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-138729

Published: 2020

Journal Articles

Assessment of the Plasmic Score Utility for Classification of Pediatric Thrombotic Microangiopathies

Grace E Linder, MD, Steven Richard Sloan, MD PhD, Pavan Bendapudi, MD, Robert Makar, MD PhD

Blood (2019) 134 (Supplement_1): 1075.

https://doi.org/10.1182/blood-2019-130608

Published: 2019

Journal Articles

Predictors of Relapse and Efficacy of Rituximab in Autoimmune Thrombotic Thrombocytopenic Purpura (TTP): A Multi-Institutional Registry-Based Analysis

Lova Sun, MD, Johnathan P. Mack, MD, Ang Li, MD, Justine Ryu, MD, Vivek A Upadhyay, MD, Robert Makar, MD PhD, Pavan Bendapudi, MD

Blood (2018) 132 (Supplement 1): 375.

https://doi.org/10.1182/blood-2018-99-110656

Published: 2018

Journal Articles

Projected Cost Savings of a Plasmic Score-Based Approach to Patients with Suspected Thrombotic Thrombocytopenic Purpura

Vivek A Upadhyay, MD, Benjamin Geisler, MD, Lova Sun, MD, Christopher P. Stowell, MD PhD, Lynne Uhl, MD, Richard Kaufman, MD, Robert Makar, MD PhD, Pavan Bendapudi, MD

Blood (2017) 130 (Supplement 1): 3742.

https://doi.org/10.1182/blood.V130.Suppl_1.3742.3742

Published: 2017

Journal Articles

Utilization and Cost Effectiveness of a Risk Stratified Diagnostic Approach to Patients with Suspected Thrombotic Thrombocytopenic Purpura

Vivek Upadhyay, MD, Benjamin Geisler, Lova Sun, MD, Robert S Makar, MD PhD, Pavan Bendapudi, MD

Blood (2016) 128 (22): 1456.

https://doi.org/10.1182/blood.V128.22.1456.1456

Published: 2016

Journal Articles

Therapeutic Plasma Exchange for the Treatment of Thrombotic Microangiopathy without Severe ADAMTS13 Deficiency: A Propensity Score-Matched Study

Ang Li, MD, Robert S Makar, MD PhD, Shelley Hurwitz, PhD, Lynne Uhl, MD, Richard M. Kaufman, MD, Christopher P. Stowell, MD PhD, Walter Dzik, MD, Pavan Bendapudi, MD

Blood (2015) 126 (23): 3471.

https://doi.org/10.1182/blood.V126.23.3471.3471

Published: 2015

NARROW

Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura

Incidence and Risk Factors for Bleeding in Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

Rare Inherited Defects of the Complement System in Purpura Fulminans

Assessment of the Plasmic Score Utility for Classification of Pediatric Thrombotic Microangiopathies

Predictors of Relapse and Efficacy of Rituximab in Autoimmune Thrombotic Thrombocytopenic Purpura (TTP): A Multi-Institutional Registry-Based Analysis

Projected Cost Savings of a Plasmic Score-Based Approach to Patients with Suspected Thrombotic Thrombocytopenic Purpura

Utilization and Cost Effectiveness of a Risk Stratified Diagnostic Approach to Patients with Suspected Thrombotic Thrombocytopenic Purpura

Therapeutic Plasma Exchange for the Treatment of Thrombotic Microangiopathy without Severe ADAMTS13 Deficiency: A Propensity Score-Matched Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only